PodParley PodParley
PodParley
Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy episode artwork

EPISODE · Nov 8, 2024 · 17 MIN

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

from PeerVoice Internal Medicine Audio · host PeerVoice

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

Episode metadata supplied by the publisher feed · Published Nov 8, 2024

Embed this episode

What this episode covers

Visit https://www.peervoice.com/CZH860 to view the entire programme with slides. After completing “Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy”, participants will be able to: Distinguish between the clinical trials examining new and emerging therapies in IgA nephropathy (IgAN); Recognize the mechanistic rationale for targeting the drivers of immunopathogenesis in IgAN; and Evaluate clinical evidence and data regarding emerging therapies in patients with IgAN.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Richard Lafayette, MD, FACP - Novel Therapies in Focus: Updates in IgA Nephropathy

0:00 17:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PeerVoice Internal Medicine Audio?

This episode is 17 minutes long.

When was this PeerVoice Internal Medicine Audio episode published?

This episode was published on November 8, 2024.

Can I download this PeerVoice Internal Medicine Audio episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!